Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	cell body fiber	SACS ASL	4.24e-04	11	59	2	GO:0070852
GeneOntologyCellularComponent	NSL complex	KANSL3 OGT	4.24e-04	11	59	2	GO:0044545
HumanPheno	Areflexia of lower limbs	SACS VPS13A SCN9A GBE1 SPG11	3.75e-05	93	22	5	HP:0002522
HumanPheno	Decreased number of peripheral myelinated nerve fibers	SACS VPS13A SCN9A SPG11	5.28e-05	50	22	4	HP:0003380
HumanPheno	Decreased/absent ankle reflexes	SACS VPS13A SCN9A GBE1	6.65e-05	53	22	4	HP:0200101
HumanPheno	Peripheral axonal neuropathy	TRAPPC11 VPS13A GBE1 SPG11 ATP11A STAT3	8.86e-05	182	22	6	HP:0003477
Domain	Na_channel_asu	SCN7A SCN9A	4.20e-04	10	58	2	IPR001696
Domain	Na_trans_assoc	SCN7A SCN9A	4.20e-04	10	58	2	IPR010526
Domain	Na_trans_assoc	SCN7A SCN9A	4.20e-04	10	58	2	PF06512
Domain	P_typ_ATPase_c	ATP11A ATP8B2	8.42e-04	14	58	2	IPR032630
Domain	P-type_ATPase_N	ATP11A ATP8B2	8.42e-04	14	58	2	IPR032631
Domain	P-type_ATPase_IV	ATP11A ATP8B2	8.42e-04	14	58	2	IPR006539
Domain	Ras_G-nucl-exch_fac_CS	RGL1 RALGDS	8.42e-04	14	58	2	IPR019804
Domain	PhoLip_ATPase_C	ATP11A ATP8B2	8.42e-04	14	58	2	PF16212
Domain	PhoLip_ATPase_N	ATP11A ATP8B2	8.42e-04	14	58	2	PF16209
Domain	RasGEFN	RGL1 RALGDS	1.74e-03	20	58	2	SM00229
Domain	RasGEF_N	RGL1 RALGDS	1.92e-03	21	58	2	PF00618
Domain	Ras-like_Gua-exchang_fac_N	RGL1 RALGDS	2.10e-03	22	58	2	IPR000651
Domain	RASGEF_NTER	RGL1 RALGDS	2.10e-03	22	58	2	PS50212
Domain	Ubiquitin-rel_dom	RGL1 RALGDS SACS OASL	2.56e-03	184	58	4	IPR029071
Domain	RASGEF	RGL1 RALGDS	2.94e-03	26	58	2	PS00720
Domain	RASGEF_CAT	RGL1 RALGDS	3.65e-03	29	58	2	PS50009
Domain	RasGEF	RGL1 RALGDS	3.90e-03	30	58	2	PF00617
Domain	-	RGL1 RALGDS	3.90e-03	30	58	2	1.10.840.10
Domain	Ras_GEF_dom	RGL1 RALGDS	3.90e-03	30	58	2	IPR023578
Domain	RASGEF_cat_dom	RGL1 RALGDS	3.90e-03	30	58	2	IPR001895
Domain	RasGEF	RGL1 RALGDS	3.90e-03	30	58	2	SM00147
Domain	RA	RGL1 RALGDS	4.16e-03	31	58	2	SM00314
Domain	-	ATP11A ATP8B2	4.43e-03	32	58	2	3.40.1110.10
Domain	-	ATP11A ATP8B2	4.43e-03	32	58	2	2.70.150.10
Domain	ATPase_P-typ_cyto_domN	ATP11A ATP8B2	5.28e-03	35	58	2	IPR023299
Domain	P_typ_ATPase	ATP11A ATP8B2	5.58e-03	36	58	2	IPR001757
Domain	RA	RGL1 RALGDS	5.58e-03	36	58	2	PF00788
Domain	ATPase_P-typ_P_site	ATP11A ATP8B2	5.58e-03	36	58	2	IPR018303
Domain	ATPASE_E1_E2	ATP11A ATP8B2	5.58e-03	36	58	2	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP11A ATP8B2	5.89e-03	37	58	2	IPR008250
Pubmed	Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry.	ANAPC1 ANAPC4 CCNA2	2.58e-07	8	59	3	26960431
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 NLRP7 PCDHGB5 SACS VPS13A SCN9A STRN4 XRN1 PDIA2 SPG11 ATP11A HMGCL NDUFS1	6.92e-07	1442	59	13	35575683
Pubmed	Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling.	OGT STAT3	2.83e-06	2	59	2	18519567
Pubmed	STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.	MITF STAT3	2.83e-06	2	59	2	14737107
Pubmed	Transcriptional intermediary factor 1γ binds to the anaphase-promoting complex/cyclosome and promotes mitosis.	ANAPC1 ANAPC4 CCNA2	3.10e-06	17	59	3	23160376
Pubmed	Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control.	UBR5 ANAPC1 ANAPC4	3.10e-06	17	59	3	29033132
Pubmed	Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex.	ANAPC1 ANAPC4 CCNA2	6.03e-06	21	59	3	18485873
Pubmed	RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.	RGL1 RALGDS	8.48e-06	3	59	2	8710374
Pubmed	Identifying a common molecular mechanism for inhibition of MITF and STAT3 by PIAS3.	MITF STAT3	8.48e-06	3	59	2	16368885
Pubmed	Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.	MITF STAT3	8.48e-06	3	59	2	15572665
Pubmed	O-Linked N-acetylglucosamine transferase 1 regulates global histone H4 acetylation via stabilization of the nonspecific lethal protein NSL3.	KANSL3 OGT	8.48e-06	3	59	2	28450392
Pubmed	Evolution and diversity of mammalian sodium channel genes.	SCN7A SCN9A	1.69e-05	4	59	2	10198179
Pubmed	Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.	NTS STAT3	1.69e-05	4	59	2	25200966
Pubmed	Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.	ATP11A ATP8B2	1.69e-05	4	59	2	25315773
Pubmed	STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.	MITF STAT3	1.69e-05	4	59	2	33323974
Pubmed	O-GlcNAc-Modification of NSL3 at Thr755 Site Maintains the Holoenzyme Activity of MOF/NSL Histone Acetyltransfease Complex.	KANSL3 OGT	1.69e-05	4	59	2	31881804
Pubmed	Paradoxical mitotic exit induced by a small molecule inhibitor of APC/CCdc20.	ANAPC1 ANAPC4 CCNA2	2.44e-05	33	59	3	32152539
Pubmed	Ubiquitin chain elongation requires E3-dependent tracking of the emerging conjugate.	ANAPC1 ANAPC4 CCNA2	2.44e-05	33	59	3	25306918
Pubmed	Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation.	OGT STAT3	2.82e-05	5	59	2	28280036
Pubmed	The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression.	ANAPC1 ANAPC4	2.82e-05	5	59	2	19826416
Pubmed	Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation.	ANAPC1 ANAPC4 CCNA2	3.46e-05	37	59	3	26811472
Pubmed	Integrated RAS signaling defined by parallel NMR detection of effectors and regulators.	RGL1 RALGDS	4.23e-05	6	59	2	24441586
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ANAPC1 DHCR24 LTN1 STRN4 NFS1 NDUFS1 STAT3	4.47e-05	560	59	7	35241646
Pubmed	SUMO targets the APC/C to regulate transition from metaphase to anaphase.	ANAPC1 DHCR24 ANAPC4	4.72e-05	41	59	3	29549242
Pubmed	The Mitotic Checkpoint Complex Requires an Evolutionary Conserved Cassette to Bind and Inhibit Active APC/C.	ANAPC1 ANAPC4	5.91e-05	7	59	2	27939943
Pubmed	Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.	OGT UBR5 DHCR24 LTN1 VPS13A CCNA2	6.70e-05	408	59	6	33766124
Pubmed	Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1.	ANAPC1 ANAPC4	7.87e-05	8	59	2	20686030
Pubmed	Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13.	STARD13 FRY	7.87e-05	8	59	2	8812419
Pubmed	Biochemical characterization of the Ras-related GTPases Rit and Rin.	RGL1 RALGDS	7.87e-05	8	59	2	10545207
Pubmed	Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.	OGT SACS UBR5	8.59e-05	50	59	3	37974198
Pubmed	Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A.	ANAPC4 CCNA2	1.01e-04	9	59	2	18471975
Pubmed	Regulation of the anaphase-promoting complex by the COP9 signalosome.	ANAPC1 ANAPC4	1.01e-04	9	59	2	19535905
Pubmed	How APC/C-Cdc20 changes its substrate specificity in mitosis.	ANAPC4 CCNA2	1.01e-04	9	59	2	21336306
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	OGT UBR5 TMEM259 DHCR24 LTN1 VPS13A NDUFS1	1.21e-04	657	59	7	36180527
Pubmed	Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons.	ANAPC1 ANAPC4	1.26e-04	10	59	2	10500174
Pubmed	The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators.	ANAPC4 CCNA2	1.26e-04	10	59	2	25669885
Pubmed	Crosstalk between NSL histone acetyltransferase and MLL/SET complexes: NSL complex functions in promoting histone H3K4 di-methylation activity by MLL/SET complexes.	KANSL3 OGT	1.26e-04	10	59	2	24244196
Pubmed	Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex.	ANAPC1 ANAPC4	1.26e-04	10	59	2	10318877
Pubmed	Intersubspecific subcongenic mouse strain analysis reveals closely linked QTLs with opposite effects on body weight.	SCN7A SCN9A	1.26e-04	10	59	2	21451961
Pubmed	Stable MCC binding to the APC/C is required for a functional spindle assembly checkpoint.	ANAPC1 ANAPC4	1.26e-04	10	59	2	24464857
Pubmed	SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.	ANAPC1 ANAPC4	1.26e-04	10	59	2	22014574
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	BHLHE23 UBR5 TMEM259 DHCR24 LTN1 OASL GBE1 NDUFS1 STAT3 CCNA2	1.42e-04	1440	59	10	30833792
Pubmed	The PP2AB56 phosphatase promotes the association of Cdc20 with APC/C in mitosis.	ANAPC1 ANAPC4	1.54e-04	11	59	2	28404789
Pubmed	Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner.	ANAPC4 CCNA2	1.54e-04	11	59	2	21241890
Pubmed	Mitotic regulation of the human anaphase-promoting complex by phosphorylation.	ANAPC1 ANAPC4	1.85e-04	12	59	2	14657031
Pubmed	Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex.	KANSL3 OGT	1.85e-04	12	59	2	20018852
Pubmed	Mad2 and the APC/C compete for the same site on Cdc20 to ensure proper chromosome segregation.	ANAPC4 CCNA2	1.85e-04	12	59	2	23007648
Pubmed	Conformation-specific anti-Mad2 monoclonal antibodies for the dissection of checkpoint signaling.	ANAPC1 ANAPC4	1.85e-04	12	59	2	26986935
Pubmed	Localization of the coactivator Cdh1 and the cullin subunit Apc2 in a cryo-electron microscopy model of vertebrate APC/C.	ANAPC1 ANAPC4	1.85e-04	12	59	2	16364912
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RGL1 SACS LTN1 ATP11A ATP8B2 RIC1	1.88e-04	493	59	6	15368895
Pubmed	The DNA sequence and analysis of human chromosome 13.	STARD13 FRY SACS ATP11A	2.03e-04	170	59	4	15057823
Pubmed	Gene expression and cell identity controlled by anaphase-promoting complex.	ANAPC1 ANAPC4 CCNA2	2.15e-04	68	59	3	32076268
Pubmed	The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.	ANAPC1 ANAPC4	2.18e-04	13	59	2	23979597
Pubmed	Differential expression of putative transbilayer amphipath transporters.	ATP11A ATP8B2	2.18e-04	13	59	2	11015572
Pubmed	MOF-associated complexes ensure stem cell identity and Xist repression.	KANSL3 OGT	2.18e-04	13	59	2	24842875
Pubmed	Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.	ANAPC1 ANAPC4	2.18e-04	13	59	2	16921029
Pubmed	HectD1 E3 ligase modifies adenomatous polyposis coli (APC) with polyubiquitin to promote the APC-axin interaction.	RNF146 STRN4	2.18e-04	13	59	2	23277359
Pubmed	MASTL promotes cyclin B1 destruction by enforcing Cdc20-independent binding of cyclin B1 to the APC/C.	ANAPC4 CCNA2	2.18e-04	13	59	2	25750436
Pubmed	Mediator of DNA damage checkpoint 1 (MDC1) regulates mitotic progression.	ANAPC1 CCNA2	2.54e-04	14	59	2	19826003
Pubmed	Characterization of vertebrate cohesin complexes and their regulation in prophase.	ANAPC1 ANAPC4	2.54e-04	14	59	2	11076961
Pubmed	The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex.	ANAPC1 ANAPC4	2.93e-04	15	59	2	10922056
Pubmed	APC15 mediates CDC20 autoubiquitylation by APC/C(MCC) and disassembly of the mitotic checkpoint complex.	ANAPC1 ANAPC4	2.93e-04	15	59	2	23007861
Pubmed	Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.	ANAPC1 ANAPC4	3.34e-04	16	59	2	10548110
Pubmed	The anaphase-promoting complex: a key factor in the regulation of cell cycle.	ANAPC1 ANAPC4	3.34e-04	16	59	2	15678131
Pubmed	Mechanism of polyubiquitination by human anaphase-promoting complex: RING repurposing for ubiquitin chain assembly.	ANAPC1 ANAPC4	3.34e-04	16	59	2	25306923
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	OGT CENPN UBR5 ANAPC1 INPP4A XRN1 SPG11 NDUFS1 CCNA2	3.76e-04	1327	59	9	32694731
Pubmed	Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1.	ANAPC1 ANAPC4	3.79e-04	17	59	2	12070128
Pubmed	A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.	ANAPC1 ANAPC4	3.79e-04	17	59	2	11340163
Pubmed	TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1.	ANAPC1 ANAPC4	3.79e-04	17	59	2	12956947
Pubmed	Atomic structure of the APC/C and its mechanism of protein ubiquitination.	ANAPC1 ANAPC4	3.79e-04	17	59	2	26083744
Pubmed	Lesson from the stoichiometry determination of the cohesin complex: a short protease mediated elution increases the recovery from cross-linked antibody-conjugated beads.	ANAPC1 ANAPC4	3.79e-04	17	59	2	21043528
Pubmed	Mechanism of APC/CCDC20 activation by mitotic phosphorylation.	ANAPC1 ANAPC4	3.79e-04	17	59	2	27114510
Pubmed	Recombinant expression, reconstitution and structure of human anaphase-promoting complex (APC/C).	ANAPC1 ANAPC4	3.79e-04	17	59	2	23078409
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	DHCR24 CD38 NTS LTN1 VPS13A SPG11 ATP8B2 ADGRA3	4.08e-04	1061	59	8	33845483
Pubmed	BubR1 blocks substrate recruitment to the APC/C in a KEN-box-dependent manner.	ANAPC1 ANAPC4	4.25e-04	18	59	2	22193957
Pubmed	The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation.	OASL STAT3	4.25e-04	18	59	2	27001747
Pubmed	Mitotic regulation of the APC activator proteins CDC20 and CDH1.	ANAPC1 ANAPC4	4.25e-04	18	59	2	10793135
Pubmed	The mitotic checkpoint: a signaling pathway that allows a single unattached kinetochore to inhibit mitotic exit.	ANAPC1 ANAPC4	4.25e-04	18	59	2	14593737
Pubmed	Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2.	ANAPC1 ANAPC4	4.25e-04	18	59	2	11535616
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	ANAPC1 LTN1 STRN4 XRN1	4.70e-04	212	59	4	33853758
Pubmed	Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation.	STAT3 CCNA2	4.75e-04	19	59	2	28067668
Pubmed	Molecular mechanism of APC/C activation by mitotic phosphorylation.	ANAPC1 ANAPC4	4.75e-04	19	59	2	27120157
Pubmed	Molecular architecture and mechanism of the anaphase-promoting complex.	ANAPC1 ANAPC4	4.75e-04	19	59	2	25043029
Pubmed	Structure of an APC3-APC16 complex: insights into assembly of the anaphase-promoting complex/cyclosome.	ANAPC1 ANAPC4	4.75e-04	19	59	2	25490258
Pubmed	APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box.	ANAPC1 ANAPC4	5.27e-04	20	59	2	11742988
Pubmed	Loss of Shp2-mediated mitogen-activated protein kinase signaling in Muller glial cells results in retinal degeneration.	MITF STAT3	5.82e-04	21	59	2	21576358
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	OGT UBR5 EXOSC6 STRN4 STAT3	5.84e-04	399	59	5	37536630
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	RALGDS XRN1 PLEK CCNA2	6.07e-04	227	59	4	26410627
Pubmed	Proximity Labeling Reveals Spatial Regulation of the Anaphase-Promoting Complex/Cyclosome by a Microtubule Adaptor.	ANAPC4 CCNA2	6.39e-04	22	59	2	35952650
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	OGT UBR5 ANAPC1 INPP4A XRN1	7.19e-04	418	59	5	34709266
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	FRY UBR5 EXOSC6 STRN4 ANAPC4 CCNA2	7.41e-04	639	59	6	23443559
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	ANAPC1 ANAPC4	7.62e-04	24	59	2	33705438
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	ANAPC1 LTN1 XRN1 NDUFS1	7.71e-04	242	59	4	34011540
Pubmed	CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling.	OGT UBR5 NDUFS1	8.34e-04	108	59	3	30166453
Pubmed	APC7 mediates ubiquitin signaling in constitutive heterochromatin in the developing mammalian brain.	ANAPC1 ANAPC4	9.66e-04	27	59	2	34942119
Pubmed	Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.	UBR5 STAT3	9.66e-04	27	59	2	21320693
Pubmed	E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.	OGT XRN1	1.04e-03	28	59	2	30277474
Pubmed	Gene expression and dental enamel structure in developing mouse incisor.	STAT3 CCNA2	1.12e-03	29	59	2	20487000
Pubmed	Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.	PLEK STAT3	1.12e-03	29	59	2	22190364
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	STARD13 MROH9 DENND1B DHCR24 VPS13A GBE1 ATP11A ATP8B2	1.14e-03	1242	59	8	30973865
Interaction	B3GALT2 interactions	TMEM259 LTN1 ADGRA3	7.64e-06	14	57	3	int:B3GALT2
Cytoband	Ensembl 112 genes in cytogenetic band chr13q13	STARD13 FRY NBEA	1.66e-04	82	59	3	chr13q13
Cytoband	4p15.2	ADGRA3 ANAPC4	6.01e-04	28	59	2	4p15.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4p15	CD38 ADGRA3 ANAPC4	7.17e-04	135	59	3	chr4p15
GeneFamily	Anaphase promoting complex \|Tetratricopeptide repeat domain containing	ANAPC1 ANAPC4	4.49e-04	14	41	2	402
GeneFamily	ATPase phospholipid transporting	ATP11A ATP8B2	5.17e-04	15	41	2	1210
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	STARD13 RGL1 OGT SACS UBR5 LTN1 MITF VPS13A GBE1 SPG11 SLC16A7 ADGRA3	3.72e-07	856	59	12	M4500
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN	SLC6A7 FRY ASL CD38 MITF STAG3	5.40e-06	197	59	6	M3438
Coexpression	NICK_RESPONSE_TO_PROC_TREATMENT_DN	UBR5 TMEM259 SPG11	3.05e-05	27	59	3	M8801
Coexpression	GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	RGL1 RALGDS CD38 MITF PLEK	4.08e-05	170	59	5	M6852
Coexpression	GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN	DENND1B CENPN INPP4A MITF OASL	7.45e-05	193	59	5	M3149
Coexpression	GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP	MROH9 PEMT SCN7A ADAM2 STAG3	8.61e-05	199	59	5	M9430
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	SLC6A7 RGL1 FRY MAN1C1 ATP11A	8.61e-05	199	59	5	M3445
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	FRY SACS ANAPC1 CD38 ATP8B2	8.82e-05	200	59	5	M9317
Coexpression	GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN	FRY OGT DENND1B INPP4A ATP8B2	8.82e-05	200	59	5	M8656
Coexpression	GSE3982_MAST_CELL_VS_BCELL_UP	DENND1B RNF146 DHCR24 COL14A1 ADGRA3	8.82e-05	200	59	5	M5434
Coexpression	GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP	DHCR24 COL14A1 ATP11A ADGRA3 ANAPC4	8.82e-05	200	59	5	M8844
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGDS OGT DENND1B SACS UBR5 MAN1C1 INPP4A XRN1 SPG11 SLC16A7 ATP8B2 STAT3	1.02e-04	1492	59	12	M40023
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP	RGL1 CD38 OASL	1.54e-04	46	59	3	M41048
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP	RGL1 CD38 OASL	1.54e-04	46	59	3	M41047
ToppCell	NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RGL1 ABHD16B CD38 OASL XRN1 PLEK	2.15e-07	193	59	6	0dd83b21e164147abfd511a927615c40a28781a2
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGL1 SCN9A NBEA PLEK SLC16A7	3.36e-06	173	59	5	b335ca2a247156eba821943b2b9fc9922230b409
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	OGT DENND1B CD38 XRN1 RIC1	4.66e-06	185	59	5	3b77bc49cd3740acc025e162a36282ac09e12198
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RGL1 DENND1B CD38 OASL XRN1	4.91e-06	187	59	5	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGL1 TRAPPC11 MAN1C1 SCN9A SLC16A7	5.17e-06	189	59	5	9e3c083174a64ea78648c6d48498fc4e721b569f
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGL1 TRAPPC11 MAN1C1 SCN9A SLC16A7	5.17e-06	189	59	5	6e19bfa52406ebe095daa99f958ec4d596ce6e39
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	3.10e-05	135	59	4	54b2aaf8d322e01a3ff6099c2422d68ecccf96b4
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	3.99e-05	144	59	4	0bbe670454846cf9bc7464ae4e91488415c4111d
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	DENND1B COL14A1 CCDC65 ADGRA3	3.99e-05	144	59	4	5e948d4cb913ccd8f82262a1b4d20967aadab3ab
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	6.47e-05	163	59	4	db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	RGL1 CD38 NTS ADAM2	6.63e-05	164	59	4	362c16ed7fb37bf16601fd5e059d3f3e2ed692b4
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	6.78e-05	165	59	4	d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	6.94e-05	166	59	4	b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MAN1C1 MITF SCN9A ADGRA3	7.27e-05	168	59	4	2572a3dd4f3f619bd26a3cd6e60de43821d8bb64
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FRY DENND1B DHCR24 MITF	7.97e-05	172	59	4	3a76cfb2832790144a6da6406469ead0767916b5
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRY SCN7A PLEK CCDC65	8.15e-05	173	59	4	1e4afa020fae682521335b440ccd33c16f37156f
ToppCell	390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CENPN CD38 ADGRA3 CCNA2	8.71e-05	176	59	4	941e8724b6f680719ef2a4f190f943b205bb9e78
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP7 INPP4A SCN9A PLEK	9.29e-05	179	59	4	4808469096cd6bec2bdfcf4fc55aa324757600c3
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NLRP7 INPP4A SCN9A PLEK	9.29e-05	179	59	4	4d55718c6afd8a038d93cc77b9b08171dab9976f
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OGT CD38 PLEK RIC1	9.91e-05	182	59	4	626aabfd9ac662c1d189f7c4b660482914d9e669
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	OGT CD38 PLEK RIC1	9.91e-05	182	59	4	a00abff41c12b71d5860c494b8c722d649fd5f36
ToppCell	CV-Healthy-7\|CV / Virus stimulation, Condition and Cluster	DENND1B DHCR24 ATP11A NDUFS1	1.03e-04	184	59	4	0e5cc77aaa73ceb791f8be7456177577fd2e5586
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	RGL1 SCN7A COL14A1 STAT3	1.03e-04	184	59	4	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC6A7 SCN7A SCN9A COL14A1	1.06e-04	185	59	4	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	RGL1 CD38 ADAM2 PLEK	1.10e-04	187	59	4	88fac9f23047892acccbcc355d02ff079596fedf
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RGL1 PCDHGB5 UBR5 XRN1	1.12e-04	188	59	4	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RGL1 PCDHGB5 UBR5 XRN1	1.12e-04	188	59	4	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RGL1 PCDHGB5 UBR5 XRN1	1.12e-04	188	59	4	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STARD13 RGL1 SCN9A PLEK	1.15e-04	189	59	4	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	Control-Plasmablast\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	NLRP7 INPP4A CD38 ATP8B2	1.19e-04	191	59	4	3df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCell	COVID-19-Myeloid-MoAM1,_IL1R2\|Myeloid / Condition, Lineage and Cell class	RGL1 CD38 OASL XRN1	1.22e-04	192	59	4	be9d5685fa03563322f147a4b38ed31e4da59487
ToppCell	BAL-Mild\|BAL / Compartment, Disease Groups and Clusters	CD38 OASL XRN1 RBM43	1.22e-04	192	59	4	1a6cbf014d3f7a3fb6f53adab078c4742e7137de
ToppCell	CV-Healthy-6\|CV / Virus stimulation, Condition and Cluster	RALGDS CD38 OASL PLEK	1.24e-04	193	59	4	1e285c31823d3e1a18d8c01748cc3604f400c954
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RGL1 CD38 OASL XRN1	1.24e-04	193	59	4	22455801194bd8c73c5c397f5eac4f723429c383
ToppCell	CD8+_Memory_T_cell-CV-6\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	RALGDS CD38 OASL PLEK	1.27e-04	194	59	4	35a347c3824757b9de8b7f49db46e73e7fb63a4f
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RGL1 CD38 OASL XRN1	1.27e-04	194	59	4	e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 RGL1 MITF PLEK	1.27e-04	194	59	4	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	RGL1 CD38 OASL PLEK	1.29e-04	195	59	4	9c9634906168239cf978adb398787692437bf9e7
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RGL1 DENND1B CD38 PLEK	1.29e-04	195	59	4	2f2e29089a8cb748d2c1329c5c8465165b25bc8b
ToppCell	NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RGL1 CD38 OASL PLEK	1.29e-04	195	59	4	d87c83d2d421c9291d0a10bc9db850e9fb337667
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RGL1 DENND1B CD38 PLEK	1.29e-04	195	59	4	c9469e2d31beb30ebb64b3f0a5239e23119fbaa5
ToppCell	CV-Moderate-1\|Moderate / Virus stimulation, Condition and Cluster	CD38 OASL XRN1 PLEK	1.32e-04	196	59	4	b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1
ToppCell	CV-Moderate-1\|CV / Virus stimulation, Condition and Cluster	CD38 OASL XRN1 PLEK	1.34e-04	197	59	4	e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	OGT VPS13A XRN1 STAT3	1.34e-04	197	59	4	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	INPP4A CD38 OASL PLEK	1.37e-04	198	59	4	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	Sigmoid-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	MAN1C1 CD38 XRN1 SLC16A7	1.37e-04	198	59	4	305d7ae9b070ac7211638a5282374c02bf13af40
ToppCell	CV\|World / Virus stimulation, Condition and Cluster	RALGDS CD38 OASL PLEK	1.37e-04	198	59	4	6a28193af35abec5c029129930c2ca6febaafde2
ToppCell	CD8+_Memory_T_cell-CV\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	RALGDS CD38 OASL PLEK	1.37e-04	198	59	4	3d1749f5106f0912f4a74615863853949f52c73d
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CENPN CD38 OASL CCNA2	1.40e-04	199	59	4	75f221c99adaa29f45dbe365f638b8b123eea148
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CENPN CD38 OASL CCNA2	1.40e-04	199	59	4	ef767641b669eb2ef3461e51548f4dd09292de90
ToppCell	severe_influenza-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	CENPN DHCR24 CD38 CCNA2	1.40e-04	199	59	4	1541f655f7d12c650added3683d07e5417a68dfb
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 SCN7A SCN9A XRN1	1.40e-04	199	59	4	a92718a3f1153b8d2196fd343ed5bc0ebc98cad7
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 SCN7A SCN9A XRN1	1.40e-04	199	59	4	8dc65662c3ca1db2ba0091332f0658abc0afc5de
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CENPN CD38 OASL CCNA2	1.42e-04	200	59	4	562309f9ca4a73cea5ed1d85b516891545f3ae5f
Disease	Intellectual Disability	RALGDS FRY SACS INPP4A NBEA HMGCL CCNA2	2.70e-05	447	58	7	C3714756
Disease	Inherited neuropathies	SACS SCN9A SPG11	6.76e-05	40	58	3	C0598589
Disease	Mental Retardation, Psychosocial	RALGDS FRY INPP4A CCNA2	1.64e-04	139	58	4	C0025363
Disease	Profound Mental Retardation	RALGDS FRY INPP4A CCNA2	1.64e-04	139	58	4	C0020796
Disease	Mental deficiency	RALGDS FRY INPP4A CCNA2	1.64e-04	139	58	4	C0917816
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN7A SCN9A	1.69e-04	10	58	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN7A SCN9A	1.69e-04	10	58	2	DOID:0080422 (implicated_via_orthology)
Disease	amino acid metabolic disorder (is_implicated_in)	ASL HMGCL	2.06e-04	11	58	2	DOID:9252 (is_implicated_in)
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN7A SCN9A	2.47e-04	12	58	2	DOID:0060170 (implicated_via_orthology)
Disease	Usual Interstitial Pneumonia	ATP11A STAT3	6.36e-04	19	58	2	C4721509
Disease	Hamman-Rich Disease	ATP11A STAT3	6.36e-04	19	58	2	C4721508
Disease	Familial Idiopathic Pulmonary Fibrosis	ATP11A STAT3	7.05e-04	20	58	2	C4721952
Disease	Idiopathic Pulmonary Fibrosis	ATP11A STAT3	7.78e-04	21	58	2	C1800706
Disease	obsolete_red blood cell distribution width	RALGDS OGT DENND1B TMEM259 RNF146 VPS13A ATP11A PLEK CCNA2	1.19e-03	1347	58	9	EFO_0005192
Disease	colon adenocarcinoma (is_implicated_in)	UBR5 STAT3	1.20e-03	26	58	2	DOID:234 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SESLLYHLSELKGMA	ANAPC4	356	Q9UJX5
LAQLLSLSMGITYDD	ADAM2	311	Q99965
MAELKSLSGDAYLAL	BHLHE23	1	Q8NDY6
AVLMDLTGSELYTQA	ADGRA3	741	Q8IWK6
SLLEESYNMELEALT	CCDC65	136	Q8IXS2
ATMTYPELGALVLDA	ABHD16B	256	Q9H3Z7
EMGTAITYQLLAILD	ATP8B2	541	P98198
DMFTLEDTLLGYLAD	CD38	141	P28907
LAVAEGLLLTSMAYD	OR2L2	106	Q8NH16
SGEMLVLDTDVFLYL	RBM43	216	Q6ZSC3
DLTMLDTALQDYIEG	RGL1	426	Q9NZL6
LMAQDLDTAASYLII	RIC1	931	Q4ADV7
ESLLSTYGEELAMLE	INPP4A	716	Q96PE3
DLLNTLLESEDSYLM	LTN1	926	O94822
DTMLVLEGSGNLVLY	ANAPC1	486	Q9H1A4
LSFAYVEGESLLMAL	NFS1	356	Q9Y697
ALALADAGVEMYDLV	EXOSC6	166	Q5RKV6
GQALSPDMLATDLAY	ASL	361	P04424
GIDEYSAAFLLSVMA	SLC16A7	276	O60669
LALAQDALDMTFGLT	PDIA2	191	Q13087
SIMASDLEPLALASY	PCDHGB5	486	Q9Y5G0
DLEPLALASYVSMSA	PCDHGB5	491	Q9Y5G0
LLDAYSGLLSNESMI	MROH9	31	Q5TGP6
LDEGFTTVMDLLLEY	OASL	256	Q15646
MESLDTPAAYSLGLA	PEMT	81	Q9UBM1
TALDGFSLEAMLTIY	NTS	91	P30990
FGLQVDEDALTYLML	GBE1	381	Q04446
LALPMASDLLLYDVT	COL14A1	441	Q05707
FVEGLLYSLDEAVIM	DHCR24	266	Q15392
ASISDAALLDIIYMQ	CENPN	61	Q96H22
YLGTFLTDLVMLDTA	RALGDS	566	Q12967
SGATVIDSLDTLYLM	MAN1C1	216	Q9NR34
LDEFLGYDDILMSSV	TMEM259	256	Q4ZIN3
ETLSLPMLAAYLDAL	KANSL3	201	Q9P2N6
GYVMEALLTLEAAVD	FRY	1906	Q5TBA9
ELVASLEDASLMGLY	C1orf127	46	Q8N9H9
SLAMFLGELSLIDAD	CCNA2	331	P20248
YSGEMDLLGEILDTL	DENND1B	561	Q6P3S1
DNLISDTSYLIAMLG	SACS	4111	Q9NZJ4
YINLAAALVAAGDME	OGT	126	O15294
GMYLEDLDVLAGTAL	STARD13	361	Q9Y3M8
LSEIAGMTLPYDTLD	NDUFS1	626	P28331
EGLMIASSLLNEGYL	PLEK	176	P08567
LATEDLVYMLEGLGI	HMGCL	276	P35914
DLLVDMLGVLASYSI	NBEA	176	Q8NFP9
MILLSSGALAFEDIY	SCN9A	1201	Q15858
TEMLIAGFLYVADLE	RNF146	136	Q9NTX7
LSANVLLDEGAMLLY	NLRP7	796	Q8WX94
VLLDDYSASFGLMVV	SLC6A7	451	Q99884
LSGLSADMQDYGLII	ATP11A	746	P98196
LKALTLMLDAAESYA	SPG11	2266	Q96JI7
DLGFIYALTDLMTEA	VPS13A	2716	Q96RL7
YADIPFLLMTDLLSA	TRAPPC11	906	Q7Z392
ISLESSYNEEILGLM	MITF	231	O75030
LLYGVLEMDAASDVF	STAG3	881	Q9UJ98
SIVSELAGLLSAMEY	STAT3	216	P40763
CLYGLDADLIMLGLT	XRN1	201	Q8IZH2
ASLFLGILAMAYEEE	SCN7A	386	Q01118
VLYDMEVGSALLTLE	STRN4	616	Q9NRL3
LLADILMAQGSYEEA	TTC34	311	A8MYJ7
SYLPGEDLMSLLDAD	UBR5	241	O95071